ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sangamo Therapeutics Inc

Sangamo Therapeutics Inc (SGMO)

0.50
0.0009
(0.18%)
At close: May 21 4:00PM
0.495
-0.005
( -1.00% )
After Hours: 7:04PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.495
Bid
0.50
Ask
0.51
Volume
4,197,547
0.4733 Day's Range 0.505
0.304 52 Week Range 3.179
Market Cap
Previous Close
0.4991
Open
0.50
Last Trade
5
@
0.511
Last Trade Time
18:51:22
Financial Volume
$ 2,085,598
VWAP
0.496861
Average Volume (3m)
7,100,361
Shares Outstanding
233,166,972
Dividend Yield
-
PE Ratio
-1.19
Earnings Per Share (EPS)
-0.42
Revenue
57.8M
Net Profit
-97.94M

About Sangamo Therapeutics Inc

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemoph... Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Sangamo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SGMO. The last closing price for Sangamo Therapeutics was $0.50. Over the last year, Sangamo Therapeutics shares have traded in a share price range of $ 0.304 to $ 3.179.

Sangamo Therapeutics currently has 233,166,972 shares outstanding. The market capitalization of Sangamo Therapeutics is $116.37 million. Sangamo Therapeutics has a price to earnings ratio (PE ratio) of -1.19.

SGMO Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0016-0.3221908981070.49660.5150.411148026590.46696334CS
4-0.295-37.34177215190.790.840.411149895900.61389183CS
12-0.4776-49.1054904380.97261.060.411171003610.7229338CS
26-1.455-74.61538461541.952.840.411167438281.18093763CS
52-0.105-17.50.63.1790.30485465701.08836733CS
156-3.695-88.18615751794.196.420.291140898861.36451106CS
260-10.495-95.495905368510.9919.430.291130385303.14728042CS

SGMO - Frequently Asked Questions (FAQ)

What is the current Sangamo Therapeutics share price?
The current share price of Sangamo Therapeutics is $ 0.495
How many Sangamo Therapeutics shares are in issue?
Sangamo Therapeutics has 233,166,972 shares in issue
What is the market cap of Sangamo Therapeutics?
The market capitalisation of Sangamo Therapeutics is USD 116.37M
What is the 1 year trading range for Sangamo Therapeutics share price?
Sangamo Therapeutics has traded in the range of $ 0.304 to $ 3.179 during the past year
What is the PE ratio of Sangamo Therapeutics?
The price to earnings ratio of Sangamo Therapeutics is -1.19
What is the cash to sales ratio of Sangamo Therapeutics?
The cash to sales ratio of Sangamo Therapeutics is 2.02
What is the reporting currency for Sangamo Therapeutics?
Sangamo Therapeutics reports financial results in USD
What is the latest annual turnover for Sangamo Therapeutics?
The latest annual turnover of Sangamo Therapeutics is USD 57.8M
What is the latest annual profit for Sangamo Therapeutics?
The latest annual profit of Sangamo Therapeutics is USD -97.94M
What is the registered address of Sangamo Therapeutics?
The registered address for Sangamo Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Sangamo Therapeutics website address?
The website address for Sangamo Therapeutics is www.sangamo.com
Which industry sector does Sangamo Therapeutics operate in?
Sangamo Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVTSNavitas Semiconductor Corporation
$ 5.63
(194.76%)
51.97M
XAGELongevity Health Holdings Inc
$ 5.06
(65.36%)
1.23M
STRRStar Equity Holdings Inc
$ 2.78
(28.12%)
475.47k
KDLYKindly MD Inc
$ 26.60
(16.51%)
505.34k
URBNUrban Outfitters Inc
$ 68.90
(15.60%)
711.9k
PTPIPetros Pharmaceuticals Inc
$ 0.0442
(-33.43%)
8.44M
WHLRWheeler Real Estate Investment Trust Inc
$ 0.8365
(-21.08%)
278.75k
VSTEVast Renewable Ltd
$ 0.1381
(-17.80%)
278.19k
BDSXBiodesix Inc
$ 0.34
(-13.95%)
5.05M
CVKDCadrenal Therapeutics Inc
$ 13.66
(-12.99%)
1k
NVTSNavitas Semiconductor Corporation
$ 5.62
(194.24%)
51.98M
GNLNGreenlane Holdings Inc
$ 0.0067
(-6.94%)
36.42M
PLRZPolyrizon Ltd
$ 0.0053
(-1.85%)
28.16M
HCTIHealthcare Triangle Inc
$ 0.0079
(-1.25%)
22.59M
LTRYLottery com Inc
$ 1.55
(-12.92%)
15.53M

SGMO Discussion

View Posts
Monroe1 Monroe1 1 week ago
That's a typical short sided statement. Eli Lily thinks it's worthy so me too.
Just bot at .46
👍️ 1
jondoeuk jondoeuk 1 week ago
The company looks pretty much done for. They are starting to put nails in the coffin.
👍️0
molee molee 4 weeks ago
$SGMO .82 Coming back up nicely with the market ... .
👍️0
Monksdream Monksdream 1 month ago
SGMO
👍️0
georgie18 georgie18 1 month ago
SGMO...749...🥳...Been adding the .60 range dip to my .90s...Market finally reacting to Lilly News...

georgie18

Member Level
Re: None

Thursday, April 03, 2025 7:52:22 PM

Post#
678758
of 679354
SGMO...92...🥳...https://www.businesswire.com/news/home/20250403023818/en/Sangamo-Therapeutics-Announces-Capsid-License-Agreement-With-Lilly-to-Deliver-Genomic-Medicines-for-Diseases-of-the-Central-Nervous-System
👍️0
Scotty9 Scotty9 1 month ago
Down down down
👍️0
jondoeuk jondoeuk 2 months ago
Wow, $18 million upfront! How long will that last?! With no milestones, they will need additional deals.
👍️0
molee molee 2 months ago
Back up to a buck after the market settles ...

Enjoy the weekend >> M
👍️0
georgie18 georgie18 2 months ago
SGMO...92...🥳...https://www.businesswire.com/news/home/20250403023818/en/Sangamo-Therapeutics-Announces-Capsid-License-Agreement-With-Lilly-to-Deliver-Genomic-Medicines-for-Diseases-of-the-Central-Nervous-System
👍 1 🚀 1
glenn1919 glenn1919 2 months ago
SGMO.......................................................................a/h
👍️0
molee molee 2 months ago
$SGMO > Shorts riding this pretty hard ... Oversold yet ?
👍️0
Monksdream Monksdream 3 months ago
SGMO, under $2

Pounds
👍️0
georgie18 georgie18 3 months ago
SGMO...$1.30...🥳...Off my $1.22 Alert...https://www.businesswire.com/news/home/20250206513390/en/

georgie18

Member Level
Re: georgie18 post# 1002

Friday, January 31, 2025 9:37:17 AM

Post#
1003
of 1003
SGMO...$1.27...🥳...on the Bollie Squeeze...Open Gap in the $2 range...

georgie18

Member Level
Re: None

Thursday, January 30, 2025 2:13:23 PM

Post#
31218
of 31261
SGMO...$1.22... https://schrts.co/IqItbIfD ...Bollie Squeeze setting up here...🥳
👍️0
georgie18 georgie18 4 months ago
SGMO...$1.27...🥳...on the Bollie Squeeze...Open Gap in the $2 range...

georgie18

Member Level
Re: None

Thursday, January 30, 2025 2:13:23 PM

Post#
31218
of 31261
SGMO...$1.22... https://schrts.co/IqItbIfD ...Bollie Squeeze setting up here...🥳
👍️0
georgie18 georgie18 4 months ago
SGMO...$1.22... https://schrts.co/IqItbIfD ...Bollie Squeeze setting up here...🥳
👍️0
georgie18 georgie18 4 months ago
SGMO...$1.45...🥳...Off my $1.03 Dip Alert...

georgie18

Member Level
Re: georgie18 post# 670316

Monday, January 06, 2025 9:52:15 AM

Post#
670503
of 670675
SGMO...$1.35s clearing here off my $1.03 Dip Alert...🥳

georgie18

Member Level
Re: georgie18 post# 996

Friday, January 03, 2025 2:29:51 PM

Post#
997
of 999
SGMO...$1.28s clearing here...🥳...Off the $1.03...Dip Alert...

georgie18

Member Level
Re: georgie18 post# 670026

Friday, January 03, 2025 8:31:17 AM

Post#
670182
of 670314
SGMO...$1.13s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 985

Thursday, January 02, 2025 9:42:07 AM

Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
👍️0
georgie18 georgie18 4 months ago
SGMO...$1.35s clearing here off my $1.03 Dip Alert...🥳

georgie18

Member Level
Re: georgie18 post# 996

Friday, January 03, 2025 2:29:51 PM

Post#
997
of 999
SGMO...$1.28s clearing here...🥳...Off the $1.03...Dip Alert...

georgie18

Member Level
Re: georgie18 post# 670026

Friday, January 03, 2025 8:31:17 AM

Post#
670182
of 670314
SGMO...$1.13s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 985

Thursday, January 02, 2025 9:42:07 AM

Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
👍️0
Monksdream Monksdream 5 months ago
SGMO under $2
👍️0
glenn1919 glenn1919 5 months ago
sgmo.......................https://stockcharts.com/h-sc/ui?s=sgmo&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 5 months ago
SGMO...$1.28s clearing here...🥳...Off the $1.03...Dip Alert...

georgie18

Member Level
Re: georgie18 post# 670026

Friday, January 03, 2025 8:31:17 AM

Post#
670182
of 670314
SGMO...$1.13s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 985

Thursday, January 02, 2025 9:42:07 AM

Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
👍️0
georgie18 georgie18 5 months ago
SGMO...$1.13s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 985

Thursday, January 02, 2025 9:42:07 AM

Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
👍️0
PonkenPlonken PonkenPlonken 5 months ago
nice year end gift to the shareholders! LOL
👍️0
PonkenPlonken PonkenPlonken 5 months ago
mind you Roche and Pfizer both shredded their AAV hem a compounds
👍️0
PonkenPlonken PonkenPlonken 5 months ago
Its when they give no roadmap!
instead tout the present - everyone knows
bios run TOWARDS events
👍️0
georgie18 georgie18 5 months ago
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
👍️0
jimr1717 jimr1717 5 months ago
Way under
👍️0
jondoeuk jondoeuk 5 months ago
PFE pulled the plug https://www.businesswire.com/news/home/20241230895593/en/Sangamo-Therapeutics-to-Regain-Full-Rights-to-Hemophilia-A-Gene-Therapy-Program-Following-Pfizer%E2%80%99s-Decision-to-Cease-Development-of-Giroctocogene-Fitelparvovec
👍️0
jondoeuk jondoeuk 5 months ago
Maybe a (future) trade for Fabry, but that’s it!
👍️0
The Canes The Canes 5 months ago
If I've ever seen an over reaction and a buying opportunity before this is Olympic!
👍️0
stockprofitter stockprofitter 5 months ago
New 52wk highs coming soon
👍️0
Monksdream Monksdream 5 months ago
SGMO under $3
👍️0
georgie18 georgie18 5 months ago
SGMO...$2.87...🥳Looking for the $3 Breakout...Last run from .30 to $3...

georgie18

Member Level
Re: None

Friday, December 13, 2024 9:33:14 AM

Post#
980
of 984
SGMO...$2.11...Starting up again...🥳
👍️0
glenn1919 glenn1919 5 months ago
sgmo...............https://stockcharts.com/h-sc/ui?s=sgmo&p=W&b=5&g=0&id=p86431144783
👍️0
harr449 harr449 5 months ago
Something going on. Up again. $2.72. Up 3%.
👍️0
georgie18 georgie18 5 months ago
SGMO...$2.66...🥳...on the Breakout...
👍️0
georgie18 georgie18 5 months ago
SGMO...$2.50...🥳...Trying for Upper Bollie Breakout here...
👍️0
georgie18 georgie18 5 months ago
SGMO...$2.11...Starting up again...🥳
👍️0
PonkenPlonken PonkenPlonken 6 months ago
Career site shows just 2 temporary positions for weeks?
Maybe has momo till december 9 presentation of the ph3 in HEM A with Pfizer.
👍️0
PonkenPlonken PonkenPlonken 6 months ago
May go to 4 first but valuation makes no sense - overbought zinc finger dud.
Smart and extensive promotion campaign by management.
👍️0
Mactheriverrat Mactheriverrat 6 months ago
SGMO - Nice day and the start of another uptrend
👍️0
glenn1919 glenn1919 6 months ago
SGMO...........................https://stockcharts.com/h-sc/ui?s=SGMO&p=W&b=5&g=0&id=p86431144783
👍️ 1
1-1 is 4 1-1 is 4 6 months ago
Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
BUSINESS WIRE 4:15 PM ET 11/19/2024
👍️0
1-1 is 4 1-1 is 4 6 months ago
HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $10 Price Target
BENZINGA 1:20 PM ET 11/14/2024
👍️0
glenn1919 glenn1919 6 months ago
sgmo.............................https://stockcharts.com/h-sc/ui?s=SGMO&p=W&b=5&g=0&id=p86431144783
👍️0
molee molee 6 months ago
$SGMO > So-So earnings report brings out the sharks ...

Where will it settle ???
👍️0
georgie18 georgie18 6 months ago
SGMO...$2.33...🥳...https://ih.advfn.com/stock-market/NASDAQ/sangamo-therapeutics-SGMO/stock-news/94894589/form-s-3-registration-statement-under-securities
👍️0
georgie18 georgie18 6 months ago
SGMO...$2.53...Fins after close...🥳

georgie18

Member Level
Re: georgie18 post# 664188

Friday, November 08, 2024 11:09:45 AM

Post#
664225
of 664553
SGMO...$3.10s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 385366

Friday, November 08, 2024 9:21:06 AM

Post#
385382
of 385395
SGMO...$3...🥳...Been waiting for this ..."W" in play here...$6 target for me...

georgie18

Member Level
Re: georgie18 post# 663989

Thursday, November 07, 2024 2:23:36 PM

Post#
664113
of 664186
SGMO...$2.83...🥳

georgie18

Member Level
Re: georgie18 post# 385311

Thursday, November 07, 2024 9:59:59 AM

Post#
385341
of 385365
SGMO...$2.65s clearing here...This was as low as .30 in July...🥳

georgie18

Member Level
Re: georgie18 post# 663756

Wednesday, November 06, 2024 2:50:09 PM

Post#
663878
of 663987
SGMO...$2.45...HOD..."W" Pattern in play here...Target $6...🥳https://schrts.co/dEUXVUBf

SGMO...$2.25...🥳

georgie18

Member Level
Re: georgie18 post# 663703

Tuesday, November 05, 2024 3:35:51 PM

Post#
663735
of 663755
SGMO...$2.14...HOD...🥳

georgie18

Member Level
Re: georgie18 post# 663630

Tuesday, November 05, 2024 1:25:37 PM

Post#
663703
of 663733
SGMO...$2.02...🥳...On Tuesday, H.C. Wainwright adjusted its outlook on shares of Sangamo BioSciences (NASDAQ:SGMO), raising the price target to $10 from the previous $5, while maintaining a Buy rating on the company's stock. The revision follows Sangamo's announcement on October 22, 2024, regarding a productive Type B meeting with the FDA about its gene therapy program for Fabry disease, isaralgagene civaparvovec (ST-920 or isa-vec).

The FDA has acknowledged that data from the ongoing Phase 1/2 STAAR trial could serve as the primary evidence for an accelerated approval process. This development could lead to a faster and more cost-effective path to submitting a Biologics License Application (BLA) than initially anticipated.



Member Level
Re: georgie18 post# 663012

Monday, November 04, 2024 4:27:39 PM

Post#
663630
of 663703
SGMO...$1.77...Fins will be announced after close on Nov 12,2024...🥳

- U.S. Food and Drug Administration (FDA) provides a clear regulatory pathway to Accelerated Approval for isaralgagene civaparvovec using data from ongoing Phase 1/2 STAAR study, avoiding requirement for additional registrational study and accelerating estimated time to potential approval by approximately three years.

- FDA confirms that estimated glomerular filtration rate (eGFR) slope data at one year across all Phase 1/2 patients can serve as primary basis for approval under Accelerated Approval pathway.

- Data to support Accelerated Approval pathway available in first half of 2025, with a potential Biologics License Application (BLA) submission expected in the second half of 2025.
👍️0
georgie18 georgie18 6 months ago
Have a Great Weekend Y'all...🥳
👍️0
molee molee 6 months ago
$SGMO earnings 11/12 . After market closes . 🚀🔥🏃💲

Enjoy the holiday weekend . >> M
👍️ 1 😃 1
georgie18 georgie18 6 months ago
SGMO...$3.10s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 385366

Friday, November 08, 2024 9:21:06 AM

Post#
385382
of 385395
SGMO...$3...🥳...Been waiting for this ..."W" in play here...$6 target for me...

georgie18

Member Level
Re: georgie18 post# 663989

Thursday, November 07, 2024 2:23:36 PM

Post#
664113
of 664186
SGMO...$2.83...🥳

georgie18

Member Level
Re: georgie18 post# 385311

Thursday, November 07, 2024 9:59:59 AM

Post#
385341
of 385365
SGMO...$2.65s clearing here...This was as low as .30 in July...🥳

georgie18

Member Level
Re: georgie18 post# 663756

Wednesday, November 06, 2024 2:50:09 PM

Post#
663878
of 663987
SGMO...$2.45...HOD..."W" Pattern in play here...Target $6...🥳https://schrts.co/dEUXVUBf

SGMO...$2.25...🥳

georgie18

Member Level
Re: georgie18 post# 663703

Tuesday, November 05, 2024 3:35:51 PM

Post#
663735
of 663755
SGMO...$2.14...HOD...🥳

georgie18

Member Level
Re: georgie18 post# 663630

Tuesday, November 05, 2024 1:25:37 PM

Post#
663703
of 663733
SGMO...$2.02...🥳...On Tuesday, H.C. Wainwright adjusted its outlook on shares of Sangamo BioSciences (NASDAQ:SGMO), raising the price target to $10 from the previous $5, while maintaining a Buy rating on the company's stock. The revision follows Sangamo's announcement on October 22, 2024, regarding a productive Type B meeting with the FDA about its gene therapy program for Fabry disease, isaralgagene civaparvovec (ST-920 or isa-vec).

The FDA has acknowledged that data from the ongoing Phase 1/2 STAAR trial could serve as the primary evidence for an accelerated approval process. This development could lead to a faster and more cost-effective path to submitting a Biologics License Application (BLA) than initially anticipated.



Member Level
Re: georgie18 post# 663012

Monday, November 04, 2024 4:27:39 PM

Post#
663630
of 663703
SGMO...$1.77...Fins will be announced after close on Nov 12,2024...🥳

- U.S. Food and Drug Administration (FDA) provides a clear regulatory pathway to Accelerated Approval for isaralgagene civaparvovec using data from ongoing Phase 1/2 STAAR study, avoiding requirement for additional registrational study and accelerating estimated time to potential approval by approximately three years.

- FDA confirms that estimated glomerular filtration rate (eGFR) slope data at one year across all Phase 1/2 patients can serve as primary basis for approval under Accelerated Approval pathway.

- Data to support Accelerated Approval pathway available in first half of 2025, with a potential Biologics License Application (BLA) submission expected in the second half of 2025.
👍️ 1

Your Recent History

Delayed Upgrade Clock